Company registration number 07112004 (England and Wales)
SILVER CROSS NURSERIES LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SILVER CROSS NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
SILVER CROSS NURSERIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£000
£000
£000
£000
Fixed assets
Investments
4
7,117
7,117
Current assets
Debtors
6
782
881
Cash at bank and in hand
-
0
1
782
882
Creditors: amounts falling due within one year
7
(733)
(721)
Net current assets
49
161
Net assets
7,166
7,278
Capital and reserves
Called up share capital
1
1
Share premium account
6,999
6,999
Other reserves
26
26
Profit and loss reserves
140
252
Total equity
7,166
7,278

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 30 July 2026 and are signed on its behalf by:
Mr C A Walsh
Director
Company Registration No. 07112004
SILVER CROSS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Silver Cross Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is Micklethorn, Broughton, Skipton, BD23 3JA.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1,000.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Fosun International Limited as at 31 December 2025. These consolidated financial statements are available from www.fosun.com.

1.2
Going concern

To assess the appropriateness of the preparation of the accounts on a going concern basis, a range of financial forecasts have been prepared to model hypothetical scenarios reflecting material deterioration in demand, or ability to meet demand, amongst other factors.  The latest cash, bank facilities and working capital position are also factored into the assessment.  Based on this assessment, the Directors have a reasonable expectation that the company have adequate resources to continue in operation for the foreseeable future.true

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.

SILVER CROSS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -

Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events thatoccurred after the initial recognition of the financial asset, the estimated future cash flows have been affected.

If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss

is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

SILVER CROSS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Investment impairment

Investments are reviewed for signs of impairment, such as loss making investments that are not expected to turn around into being profit making, or investments which no longer fit in the strategy of the group.

 

Identification and calculation of the impairment requires judgements to be maded based on a number of factors incluyding projected profits, cashflows and future plans of the subsidiaries.

SILVER CROSS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
0
0
4
Fixed asset investments
2025
2024
£000
£000
Other investments other than loans
7,117
7,117
5
Subsidiaries

Details of the company's subsidiaries at 31 December 2025 are as follows:

Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Indirect
Silver Cross (UK) Limited
1
Manufacture of prams and related nursery products
Ordinary
100.00
-
Silver Cross (Pacific) Limited
2
Manufacture of prams and related nursery products
Ordinary
100.00
-
Silver Cross (IP) Limited
1
Owner of intellectual property
Ordinary
100.00
-
Micralite (Holdings) Limited
1
Holding company
Ordinary
100.00
-
Micralite Limited
1
Manufacture of prams and related nursery products
Ordinary
0
100.00
Micralite (IP) Limited
1
Owner of intellectual property
Ordinary
0
100.00

Registered office addresses (all UK unless otherwise indicated):

1
Micklethorn, Broughton, Skipton, BD23 3JA
2
1 Sunning Road, Causeway Bay, Hong Kong
6
Debtors
2025
2024
Amounts falling due within one year:
£000
£000
Trade debtors
-
0
(1)
Amounts owed by group undertakings
782
882
782
881

Amounts owed by group undertakings are interest free and repayable on demand.

SILVER CROSS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
7
Creditors: amounts falling due within one year
2025
2024
£000
£000
Amounts owed to group undertakings
688
683
Other creditors
45
38
733
721

Amounts owed to group undertakings are interest free and repayable on demand.

8
Parent company

The company is a wholly owned subsidiary of Plata Cross (UK) Limited, a company registered in the United Kingdom, which itself is an indirect subsidiary of Fosun International Limited, a company registered in Hong Kong. The principal place of business of Fosun International Limited is, Tower S1, Bund Finance Centre, 600 Zhongshan No. 2 Road (E), Shanghai China.

 

The ultimate parent undertaking of the group for which consolidated financial statements are drawn up is Fosun International Limited. Fosun International Limited is deemed to be the controlling party. Copies of the group financial statements can be obtained from www.fosun.com.

9
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Daisy Marsden
Statutory Auditor:
Azets Audit Services Limited
Date of audit report:
31 July 2026
2025-12-312025-01-01falsefalsefalse31 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr C A WalshMr N J PaxtonMr K ShiR HuangMrs Q LiMr T HuMs Y YuanMr C A Walsh071120042025-01-012025-12-31071120042025-12-31071120042024-12-3107112004core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3107112004core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3107112004core:CurrentFinancialInstruments2025-12-3107112004core:CurrentFinancialInstruments2024-12-3107112004core:ShareCapital2025-12-3107112004core:ShareCapital2024-12-3107112004core:SharePremium2025-12-3107112004core:SharePremium2024-12-3107112004core:OtherMiscellaneousReserve2025-12-3107112004core:OtherMiscellaneousReserve2024-12-3107112004core:RetainedEarningsAccumulatedLosses2025-12-3107112004core:RetainedEarningsAccumulatedLosses2024-12-3107112004bus:CompanySecretaryDirector12025-01-012025-12-31071120042024-01-012024-12-3107112004core:Subsidiary12025-01-012025-12-3107112004core:Subsidiary22025-01-012025-12-3107112004core:Subsidiary32025-01-012025-12-3107112004core:Subsidiary42025-01-012025-12-3107112004core:Subsidiary52025-01-012025-12-3107112004core:Subsidiary62025-01-012025-12-3107112004core:Subsidiary112025-01-012025-12-3107112004core:Subsidiary222025-01-012025-12-3107112004core:Subsidiary332025-01-012025-12-3107112004core:Subsidiary442025-01-012025-12-3107112004core:Subsidiary552025-01-012025-12-3107112004core:Subsidiary662025-01-012025-12-3107112004bus:PrivateLimitedCompanyLtd2025-01-012025-12-3107112004bus:FRS1022025-01-012025-12-3107112004bus:Audited2025-01-012025-12-3107112004bus:Director12025-01-012025-12-3107112004bus:Director22025-01-012025-12-3107112004bus:Director32025-01-012025-12-3107112004bus:Director42025-01-012025-12-3107112004bus:Director52025-01-012025-12-3107112004bus:Director62025-01-012025-12-3107112004bus:Director72025-01-012025-12-3107112004bus:CompanySecretary12025-01-012025-12-3107112004bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3107112004bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP